We know from our own daily life that the establishment of long-lasting memory or learning often requires the repetition of experience. In behavioral experiments in animals, it is a standard protocol to apply repeated training or task performance in order to establish learning in either vertebrates[@b1][@b2] or invertebrates[@b3][@b4]. However, the cellular mechanisms that underlie this repetition-dependent consolidation of memory remain unclear.

In organotypic slice cultures of the rodent hippocampus, we previously demonstrated that 3 repeated inductions of long-term potentiation (LTP) by chemical means led to a slowly developing (requiring \~ 1 week for full development) and long-lasting (lasting more than 2 weeks after its development) enhancement of synaptic transmission in the CA3-CA1 synapses, and this was accompanied by the formation of new synaptic structures[@b5][@b6]. We named this novel structural plasticity phenomenon repetitive-LTP-induced synaptic enhancement (RISE).

In contrast, when we induced long-term depression (LTD, a phenomenon that is apparently symmetrical to LTP) 3 times by chemical means, a slowly developing and long-lasting synaptic suppression that was apparently symmetrical to RISE was provoked, which was coupled to the elimination of existing synapses[@b7][@b8]. We called this phenomenon LTD-repetition-operated synaptic suppression (LOSS). We propose that RISE and LOSS are *in vitro* model phenomena appropriate for cell biological analyses of the repetition-dependent consolidation of memory. In addition, we hypothesized that these 2 opposite forms of structural plasticity are mediated by brain-derived neurotrophic factor (BDNF) and its precursor proBDNF.

BDNF is a 119-amino-acid-long basic polypeptide and has been long known as an antiapoptotic protein, a promoter of neurite extension in developing nervous systems, and an inducer of synapse formation in developed brain[@b9][@b10][@b11][@b12]. BDNF is synthesized in its precursor form (proBDNF), which has a preceding acidic polypeptide composed of 110 amino acids at the N-terminus that is cleaved later by processing proteases to generate mature BDNF (mBDNF). Recently, proBDNF has been shown to have its own biological effects that are quite opposite to mBDNF. It acts as a proapoptotic factor and a neurite extension suppressor in the developing brain and a synapse elimination inducer in the developed brain. These symmetrical activities of mBDNF and proBDNF are called the yin-yang effect of this neurotrophin[@b13][@b14][@b15]. In relation to RISE and LOSS, a RISE-producing stimulus increases the levels of expression of BDNF mRNA and protein[@b16], and a LOSS-producing stimulus increases the cellular content of proBDNF[@b17]. mBDNF is known to bind to receptor tyrosine kinase TrkB as a high-affinity receptor and to p75 neuroptophin receptor (p75^NTR^) as a low-affinity receptor[@b18][@b19]. proBDNF primarily binds to p75^NTR^, but it can also bind to TrkB[@b13][@b20].

From these facts, we hypothesized that RISE is produced through activation of the mBDNF-TrkB signaling pathway, whereas LOSS is produced through activation of the proBDNF-p75^NTR^ signaling pathway[@b17]. If this is true, it is logically expected that a RISE-producing stimulus should produce LOSS when TrkB is masked, and a LOSS-producing stimulus should produce RISE when p75^NTR^ is masked. In the present study, we conducted these experiments to test our hypothesis.

Results
=======

In this study, we used organotypic slice cultures of the mouse hippocampus instead of those of the rat hippocampus used previously. The reasons for this choice were to demonstrate that RISE and LOSS are not species-specific phenomena and to prepare for the wider use of transgenic animals. As expected, mouse cultures showed equivalent structural plasticity phenomena as those that have been shown previously in rat cultures[@b5] (see also [Supplementary Fig. S1](#s1){ref-type="supplementary-material"} on line).

Mature form of BDNF (mBDNF) has long been known as an inducer of synapse formation[@b11]. In the present mouse slice culture, the application of mBDNF for 4 days produced RISE-equivalent synaptic strength enhancement that was coupled with an increase in synapse number when assayed 14 days later ([Fig. 1a--c](#f1){ref-type="fig"}). We have previously shown[@b16] that a RISE-producing stimulus (3 repeated inductions of LTP) results in increased levels of expression of the mRNA and protein of BDNF, suggesting the involvement of BDNF in the development of RISE. In fact, the application of a BDNF scavenger, which is a chimeric molecule of TrkB and IgG-Fc[@b21], inhibited the establishment of RISE after the third induction of chemical LTD ([Fig. 1d--f](#f1){ref-type="fig"}). mBDNF exerts its effects by activating its high-affinity receptor TrkB[@b18]. As expected, the application of a function-blocking antibody against TrkB[@b22] after the third LTP induction inhibited the establishment of RISE ([Fig. 2](#f2){ref-type="fig"}).

Here, we needed to be cautious about the possibility that the BDNF scavenger might interfere with the induction of LTP, because, if it occurred, the LTP would be induced only twice. In acute hippocampal slice preparations, the BDNF scavenger actually inhibited the maintenance of LTP[@b23][@b24][@b25], and we confirmed this (see [Supplementary Fig. S2](#s1){ref-type="supplementary-material"} on line). Keeping this in mind, in the experiments shown in [Fig. 1](#f1){ref-type="fig"} and [Fig. 2](#f2){ref-type="fig"}, we began the application of the BDNF scavenger after waiting 60 min following the withdrawal of forskolin (FK) in order to allow the maintenance of LTP for at least 80 min. We suspected that 80 min of LTP was still insufficient for the development of RISE; therefore, we sometimes waited 3 hours before applying the BDNF scavenger, and the results were the same (see [Supplementary Fig. S3](#s1){ref-type="supplementary-material"} on line).

The fact that the BDNF scavenger affected the FK-induced LTP in the present specimens suggested that the release of endogenous mBDNF accompanied each of the 3 LTP inductions. This led to the question of what would be the result when TrkB was masked upon all 3 LTP inductions. As shown in [Fig. 3](#f3){ref-type="fig"}, such prolonged masking of TrkB by a function-blocking antibody resulted not in a simple inhibition of RISE establishment but instead in an apparent reversal of RISE to LOSS. This result was readily explained by the alternative activations of p75^NTR^ by mBDNF when TrkB was masked chronically. In support of this explanation, neither RISE nor LOSS resulted when both TrkB and p75^NTR^ (by a function-blocking antibody[@b26][@b27] of p75^NTR^) were masked.

Thereon we performed a symmetrical examination: what would be the result if a LOSS-producing stimulus (3 repeated inductions of chemical LTD) was given when p75^NTR^ was masked during all 3 LTD inductions. As shown in [Fig. 4a--c](#f4){ref-type="fig"}, the prolonged masking of p75^NTR^ by the antip75^NTR^ antibody did not result in a simple inhibition of LOSS establishment but instead resulted in an apparent reversal from LOSS to RISE. This result was explained by the alternative activations of TrkB by proBDNF when p75^NTR^ was masked chronically. When both TrkB and p75^NTR^ were masked, the LOSS-producing stimulus produced neither RISE nor LOSS.

The alternative TrkB activation assumed here was confirmed by an immunoblotting analysis ([Fig. 4d, e](#f4){ref-type="fig"}) in which significant phosphorylation of TrkB was recognized. The expression levels of TrkB and p75^NTR^ proteins were not affected significantly by the antibody treatment.

Confirmation of the alternative activation of p75^NTR^, when a RISE-producing stimulus was given under TrkB-masking conditions, was desired but it was not conducted, since the downstream signals of p75^NTR^ are still undetermined.

Discussion
==========

The aim of the present study was to examine our hypothesis that the two apparently symmetrical long-lasting structural plasticity phenomena, RISE[@b5] and LOSS[@b7], are mediated by the yin-yang effects of mBDNF and proBDNF.

There have been many reports demonstrating that mBDNF increases synaptic strength and promotes synapse formation[@b23][@b28][@b29]. There are accumulating lines of evidence that proBDNF lowers synaptic strength and drives synapse elimination[@b30][@b31]. In slice cultures of the rodent hippocampus, exogenously applied mBDNF and proBDNF produce synapse formation and elimination, respectively ([Fig. 1](#f1){ref-type="fig"} of this report and Fig. 4 of Egashira *et al*.[@b17]). However, these results do not necessary prove that endogenous mBDNF and proBDNF mediate RISE and LOSS. Thus, we applied a BDNF scavenger here to neutralize the endogenous neurotrophin.

Although it is desired to quantify directly the absolute amounts of BDNF and proBDNF released (setting aside their cellular contents) to prove their involvement in RISE and LOSS, such quantification is still difficult, since released BDNF is quickly bound to TrkB, p75^NTR^ and the extracellular matrices[@b32] and proBDNF is rapidly converted to BDNF[@b15]. So we chose a strategy to use function-blocking antibodies against endogenous neurotrophin receptors.

BDNF binds to TrkB with high affinity and transmits neurotrophic signals in the cell through multiple pathways; however, it also binds to p75^NTR^ with low affinity[@b11]. proBDNF binds to p75^NTR^ and transmits antineurotrophic signals through an intracellular pathway unspecified yet[@b14], and it also binds to TrkB[@b20]. Hence, when their proper receptors are masked, mBDNF and proBDNF should bind alternatively to their substitute receptors in order to transmit inverse signals into the cell. The present results demonstrated that this actually occurs, thus, providing support for the aforementioned hypothesis.

It is possible that TrkB masking might have transformed LTP to LTD. If so, the 3 repeated LTP inductions would have been 3 repeated inductions of LTD, which should eventually lead to LOSS. However, Lu *et al.*[@b33] as well as [Fig. S2](#s1){ref-type="supplementary-material"} of this report indicate that TrkB masking interferes with the maintenance of LTP but does not cause LTD. In TrkB-knockout mice, LTP becomes short-lasting; but it is not transformed to LTD[@b34]. The possibility that the p75^NTR^-masking may have transformed LTD to LTP should also be low because the knockout of p75^NTR^ diminished LTD but did not reverse LTD to LTP[@b31].

It is a matter of argument whether masking of neurotrophin receptors by antibodies is possible. In literature, the binding affinity of BDNF to p75^NTR^ is \~ 10^−9^ M in dissociation constant (Kd), whereas that to TrkB is \~ 10^−11^ M (ref. [@b19]). Assuming the Kd of anti-TrkB antibody\'s binding to TrkB 10^−10^ M, the most common value of antibody binding to antigen, BDNF could defeat the antibody in the competition of binding to TrkB. However, this high binding affinity of BDNF to TrkB is realized through its concomitant binding to p75^NTR^ and the binding of BDNF to TrkB solely is \~ 10^−9^ M in Kd, which is similar to its binding to p75^NTR^ (ref. [@b35]). This situation is equivalent to the case of NGF\'s binding to TrkA and p75^NTR^ (ref. [@b36]). Therefore, it is likely that anti-TrkB antibody defeats BDNF in the competition of binding to TrkB and that BDNF alternatively binds to p75^NTR^. The same argument is applicable to the masking of p75^NTR^ by anti-p75^NTR^ antibody. The Kd value of proBDNF and p75^NTR^ is not found in literature, but applying the value of IC50 (\~10^−8^ M) obtained by neutralization experiment of proBDNF by a p75^NTR^-Fc scavenger[@b14], the masking of p75^NTR^ by the anti-p75^NTR^ antibody is expectable.

For the inhibition of biological effects by antibodies, we have to take the numbers of molecules of ligands, receptors and antibodies into account, in addition to the issues of affinities. However, we presently did not estimate them because of technical difficulties mentioned above. It is also difficult to estimate the penetration of antibodies into the tissue. Thus, we cannot calculate to which proportions the TrkB and p75^NTR^ molecules were masked actually. Nevertheless, in our previous study[@b17], the biological effects of both endogenous proBDNF and exogenously applied cleavage-resistant proBDNF (100 ng/mL, equivalent to 3.8 nM on a monomer basis) were inhibited by the anti-p75^NTR^ antibody at a dose identical to that we use here. Tanaka et al.[@b22] applied anti-TrkB antibody at a dose similar to ours to the cultured rat hippocampal slices and effectively inhibited the biological effect of BDNF.

The alternative activation of TrkB under the p75^NTR^-masking conditions was demonstrated by detecting phosphorylated TrkB ([Fig. 4](#f4){ref-type="fig"}). The antibody used here to detect phospho-TrkB also recognizes phospho-TrkA and phospho-TrkC. Hence, the increased level of phospho-Trk may not represent the increase level of phospho-TrkB. But with considering that a RISE-producing stimulus was nullified by a BDNF-scavenger ([Fig. 1](#f1){ref-type="fig"}), it is unlikely that a LOSS-producing stimulus under p75^NTR^-masking condition activates TrkA or TrkC instead of TrkB to bring about a phenomenon equivalent to RISE.

Now that we have obtained supports to the hypothesis that RISE and LOSS are mediated by the mBDNF-TrkB and proBDNF-p75^NTR^ signaling pathways, respectively, we next need to test how cells use mBDNF and proBDNF differentially, because both molecules are products of the same gene. Transcriptional or translational control seems impossible. The site of conversion (i.e., limited proteolysis by some processing proteases) from proBDNF to mBDNF is under debate[@b30][@b37]. If the conversion occurs intracellularly, we have to assume that there is a differential exocytotic mechanism between mBDNF-containing (i.e., protease-possessing) vesicles and proBDNF-containing (i.e., protease-lacking) vesicles. If the conversion occurs after exocytosis, we can assume that there is a mechanism that regulates extracellular protease activity. Recently, a new possibility has been presented, which states that the conversion occurs intracellularly but the excised propeptide co-exists in equimolar amounts within the vesicle without further decomposition[@b38]. The propeptide (which is an acidic polypeptide) binds to mBDNF (which is a basic polypeptide) to reconstruct a proBDNF-equivalent complex (M. Kojima, personal communication). If this is the case, there must be a mechanism modifying the electrostatic interactions between those polypeptides.

RISE in slice cultures of the rodent hippocampus has the following properties: 3 repetitions of LTP induction are necessary and sufficient[@b5]; the protein kinase A-dependent phase of LTP is mandatory[@b6], the repetition must have intervals of 3--24 hours[@b5][@b6]; RISE is not an extension of LTP, since it develops after the third LTP disappears[@b5][@b6]; it occurs input pathway-specifically as shown by pathway bisection and electric tetanization onto one of the pathways[@b39]; RISE is accompanied by expression of a set of cytoskeleton-regulating proteins[@b16]; the increase in the number of dendritic spines is the result of increased fluctuation followed by a biased fluctuation[@b40]; the spines do not divide but bud newly from dendritic shaft[@b40][@b41]; an equivalent synapse formation is reproducible in dissociated hippocampal cell cultures[@b42][@b43]; an opposite long-lasting structural plasticity, or LOSS, is produced after repeated inductions of LTD[@b7][@b8][@b17]. In addition to these phenomenological aspects, with the possible contribution of BDNF and proBDNF to RISE and LOSS shown here, these phenomena provide a mechanistic clue to the repetition-dependent consolidation of memory.

Methods
=======

Organotypic slice culture of the mouse hippocampus
--------------------------------------------------

Neonates of C57BL/6J mice (Japan SLC, Inc., Hamamatsu, Japan) of postnatal days 6--7 (both sexes) were sacrificed after anesthetization. The hippocampi were isolated, and 400-μm-thick slices were cut perpendicularly to the long axis of the tissue from the middle 1/3 portion with a Mcllwain tissue chopper. Four or 5 slices were placed on top of a polytetrafluoroethylene membrane (Millicell-CM, EMD Millipore Corporation, Billerica, MA, USA) and submerged in culture medium that was composed of 50% minimal essential medium based on Hanks\' salts, 25% Hanks\' buffered saline and 25% heat-inactivated house serum (all from Life Technologies Corporation, Grand Island, NY, USA). The cultures were maintained at 34°C in a humidified atmosphere for 13--15 days until maturation[@b5][@b41] with the medium renewed every 3--4 days.

Chemical induction of LTP and LTD
---------------------------------

To maintain the cultures aseptically for 2--3 weeks after the LTP/LTD inductions, we adopted chemical means to induce LTP/LTD. LTP was induced by FK (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), an adenylyl cyclase activator and thus an inducer of late phase-LTP, according to conventional protocol[@b5]. The stimulation medium containing 20 μM FK was prepared immediately before use. The 13--15 days *in vitro* culture was exposed to the stimulation medium and kept at 34°C for 20 min, which was followed by washing with a serum-free medium and bathing in a fresh culture medium. For the control groups, the culture was treated the same way except for the inclusion of FK in the stimulation medium.

LTD was induced by the application of 3,5-dihydroxyphenylglycine (DHPG; Tocris Bioscience, Bristol, UK), an agonist of group-I metabotropic glutamatergic receptors, according to a conventional protocol[@b17]. The culture was exposed to 50 μM of DHPG dissolved in a balanced salt solution (in mM: 149 NaCl, 5 KCl, 2 MgSO~4~, 2.5 CaCl~2~, 10 glucose, 10 HEPES-NaOH, pH 7.3) and kept at 34°C for 10 min, which was followed by washing with a serum-free medium and bathing in a fresh culture medium.

The same LTP- and LTD-inducing procedures were repeated 3 times at 24-hour intervals to produce RISE and LOSS, respectively. The day of the first induction of LTP/LTD was reckoned as poststimulus (PS) day 0.

The following drugs and chemicals were applied after or concomitantly with the LTP/LTD induction(s): anti-TrkB antibody (1:1,000; 610101; BD Biosciences, Franklin Lakes, NJ, USA), anti-p75^NTR^ antibody (1:1,000; AB1554; EMD Millipore Corporation), BDNF (100 ng/mL; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA), and TrkB-Fc (1 μg/mL; Sigma-Aldrich Co., St. Louis, MO, USA). The onsets and durations of the drug applications are described in the text and are shown diagrammatically in the timeline in each figure.

Electrophysiology
-----------------

The culture was transferred to a recording chamber perfused with artificial cerebrospinal fluid (ACSF; composed of \[in mM\]: 126 NaCl, 5 KCl, 1.25 NaH~2~PO~4~, 2.5 CaCl~2~, 2.0 MgSO~4~, 22 NaHCO~3~, 10 glucose). The ACSF was bubbled with a gas mixture (95% O~2~/5% CO~2~) to maintain the pH at 7.3 and perfused at 1.0 mL/min. A tungsten monopolar electrode was placed at the CA3 pyramidal cell layer, and test stimuli were delivered every 30 sec. Synaptic responses were recorded with a glass microelectrode filled with ACSF with an input resistance of 1--5 MΩ and placed in the CA1 pyramidal cell layer.

We followed the standard protocol for estimating synaptic strength in cultured slices[@b5]. In studies that use acute slices, usually the slope of field excitatory postsynaptic potentials (fEPSP) recorded from the dendritic layer is monitored. In the case of cultured slices, however, the dendritic fEPSP slopes vary markedly among the specimens, presumably because of the imperfect myelination of input axons. The comparison by fEPSP slopes assumes *a priori* the coherent onset of EPSPs in the population of neurons under examination. However, this does not hold in a cultured slice. The fEPSP slope recorded in a cultured slice does not represent a sum of the slopes of individual EPSPs, instead a degree of coherence in the onset of EPSPs evoked by inputs arriving nonuniformly in time. Therefore, as Muller *et al.*[@b44] have emphasized, the fEPSP amplitude, rather than the slope, is a better measure of the synaptic strength in cultured slices. In addition, because we needed to know the total synaptic input to the CA1 neurons that represents the number of synapses possessed by the neurons, we applied supramaximal stimulation (usually 0.3 mA) to activate practically all functional input fibers and recorded fEPSPs that were integrated at the somatic layer. By recording those maximal fEPSPs from at least 3 sites in the CA1 region for each culture, we adopted the largest value of the maximal fEPSP amplitudes as a representative value of the synaptic strength for that culture.

Lucifer yellow injections
-------------------------

Intracellular injections of fluorescent dye were conducted following the methods of Pace *et al.*[@b45] with slight modifications. The cultured slice was fixed mildly with 2% paraformaldehyde in a balanced salt solution, and a glass micropipette filled with 8% Lucifer yellow Li salt (LY; Nacalai Tesque, Inc., Kyoto, Japan) was inserted slowly into the CA1 pyramidal cell layer. Penetration of the micropipette into the pyramidal cell was recognizable by the sudden emergence of cell-shaped fluorescence. A negative current (1--3 nA) was applied for 3--5 min through the micropipette. The LY injection was performed on 1 or 2 cells for each slice. The slice was then fixed overnight with 4% paraformaldehyde.

Quantification of spine density
-------------------------------

The slices that were injected with LY were imaged by a laser scanning confocal microscope (FV-300; Olympus Corporation, Tokyo, Japan) equipped with a water immersion objective lens (UplanSApo 60X, NA 1.20). The Z-axis step was 0.5 μm. A dendritic segment of a secondary (or occasionally tertiary) branch of an apical dendrite located 100 μm or less from the soma and ran horizontally for 10--30 μm was subjected to spine number (density) counting. To identify the spines, we followed the criterion of Holtmaat *et al.*[@b46]. The number of spines was divided by the segment length to obtain the density.

Immunoblotting analysis
-----------------------

Five cultured slices of the same treatment group were removed from the polytetrafluoroethylene membrane filter and lysed with an ice-cold lysis buffer (composed of \[in mM\] 20 Tris HCl \[pH 7.4\], 300 NaCl, 1 EDTA, 10 NaF, 10 sodium pyrophosphate, 0.1 phenylarsine oxide, 1% Triton X-100, 1% phosphatase inhibitor \[Sigma-Aldrich Co.\] and 1% protease inhibitor \[Roche Diagnostics GmbH, Mannheim, Germany\]). The lysate was centrifuged at 15,000 rpm for 10 min at 4°C, and the supernatant was boiled at 100°C for 10 min. The samples were loaded onto 10% SDS gels and separated by applying a constant voltage of 200 V for 35 min, and then the proteins were transferred onto a polyvinylidene difluoride membrane (Bio-Rad Laboratories, Inc., Hercules, CA, USA) at a constant voltage of 60 V for 4 hours. After blocking with a blocking buffer (composed of 2% bovine serum albumin and 0.05% Tween-20) for 30 min, the membranes were washed with Tris-buffered saline with Tween-20 (TBS-T; composed of 150 mM NaCl, 100 mM Tris and 0.1% Tween-20 \[pH 7.2\]) and incubated with primary antibodies overnight at 4°C. The primary antibodies used were anti-phosphorylated Trk (9141S; 1:1,000; Cell Signaling Technology, Inc., Danvers, MA, USA), anti-TrkB (1:1,000; 610101; BD Biosciences), anti-p75^NTR^ (1:2000; AB1554; EMD Millipore) and anti-TUJ1 (1:3,000; Covance, Inc., Princeton, NJ, USA) diluted in TBS-T. The membranes were washed with TBS-T and incubated with horseradish peroxidase-conjugated secondary antibodies (1:10,000; Jackson ImmunoResearch Laboratories, Inc., West Grove, PA, USA) for 30 min at room temperature. After washing with TBS-T, a luminol-based chemiluminescence assay kit (Chemi-Lumi One Super; Nacalai Tesque) for the horseradish peroxidase reaction was used and the membranes were exposed to radiographic film (RX-U; Fuji Film, Tokyo, Japan). The images of the protein bands were quantified with ImageJ software. The band density was normalized to that of TUJ1.

Statistical analysis
--------------------

All experiments were repeated using cultures prepared from more than 2 litters. The numbers of examined specimens are indicated in the figure legends. All data are presented as mean ± standard error of means. For statistical comparisons between groups, at first, the normality of the data was assessed using χ^2^ tests for goodness of fit, and then the homogeneity of variance was assessed using Bartlett\'s test. Because all of the data, except for the data from the immunoblotting experiment ([Fig. 4d, e](#f4){ref-type="fig"}), showed normal distributions and non-different variances, they were further analyzed by one-way ANOVA followed by a Tukey-Kramer test. The data for the immunoblotting experiment ([Fig. 4e](#f4){ref-type="fig"}) were analyzed by a Steel-Dwass test. The levels of significance are indicated by the asterisks: \* for *P* \< 0.05, \*\* for *P* \< 0.01, and \*\*\* for *P* \< 0.001 in all the figures.

Animal care
-----------

This study was conducted in accordance with the Regulation on Animal Experiments of the Animal Experiments Committee of Osaka University. The protocols were approved by the Committee for Animal Experiments of our School (No. 12-027).
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![Possible involvement of BDNF signaling in the long-lasting synaptic enhancement induced by repetitive inductions of LTP.\
(a--c) Increases in synaptic strength and spine density produced by a 4-day application of mature BDNF (mBDNF). (a) Timeline of the experimental procedures. The day of BDNF application, which corresponded to 13--15 days *in vitro*, is reckoned as poststimulus (PS) day 0. The electrical and morphometric assays were performed on PS days 14--21. (b) The synaptic strength, as indicated by the maximal fEPSP amplitude (see Methods for explanation), is shown together with representative recordings. The numbers of slices examined were 16 for control (mock), 10 for BDNF and 14 for BDNF + TrkB-Fc. The scale bars are 10 msec (horizontal) and 1 mV (vertical). (c) The dendritic spine density is shown together with representative images of dendritic segments. The numbers of segments \[slices\] examined were 43 \[13\] for control, 24 \[9\] for BDNF and 41 \[12\] for BDNF + TrkB-Fc. The scale bar indicates 2 μm. (d--f) Increases in synaptic strength and spine density produced by 3 repeated inductions of chemical LTP and inhibition by TrkB-Fc. (d) Timeline of the experimental procedures. TrkB-Fc, a BDNF scavenger, is applied for 3 days beginning 1 hour after the third LTP induction. (e) The synaptic strength is shown together with representative recordings. The numbers of slices examined were 18 for control (3 × mock), 19 for 3 × forskolin (FK) and 12 for 3 × FK + TrkB-Fc. The scale bars are 10 msec (horizontal) and 1 mV (vertical). (f) The dendritic spine density is shown together with representative images of dendritic segments. The numbers of dendritic segments \[slices\] are 31 \[6\] for control, 47 \[11\] for 3 × FK and 26 \[8\] for 3 × FK + TrkB-Fc. The scale bar indicates 2 μm. Statistical significance is indicated by asterisks: The *P* values are 0.018 for \*1, 0.046 for \*2, 7.28 × 10^−5^ for \*\*\*3, 2.34 × 10^−5^ for \*\*\*4, 1.77 × 10^−6^ for \*\*\*5, 8.37 × 10^−6^ for \*\*\*6, 1.88 × 10^−9^ for \*\*\*7 and 1.24 × 10^−5^ for \*\*\*8.](srep03185-f1){#f1}

![The anti-TrkB antibody inhibits the long-lasting synaptic enhancement induced by repetitive inductions of LTP.\
(a) Timeline of the experimental procedures. The anti-TrkB antibody was applied for 3 days after 3 × FK applications beginning 1 hour after the third LTP induction. (b) The synaptic strength, as indicated by the maximal fEPSP amplitude, is shown together with representative recordings. The numbers of slices examined are 14 for control (3 × mock), 13 for 3 × FK and 8 for 3 × FK + anti-TrkB. The scale bars are 10 msec (horizontal) and 1 mV (vertical). (c) The dendritic spine density is shown together with representative images of the dendritic segments. The numbers of segments \[slices\] examined are 25 \[5\] for control, 24 \[7\] for 3 × FK and 24 \[6\] for 3 × FK + TrkB-Fc. The scale bar indicates 2 μm. The *P* values are 2.63 × 10^−5^ for \*\*\*1, 0.0066 for \*\*2, 8.48 × 1 0^−6^ for \*\*\*3 and 1.10 × 10^−5^ for \*\*\*4.](srep03185-f2){#f2}

![Prolonged application of the anti-TrkB antibody during repetitive inductions of LTP leads to a reversal of synaptic enhancement.\
(a) Timeline of the experimental procedures. (b) The synaptic strength, as indicated by the maximal fEPSP amplitude, is shown together with representative recordings. The numbers of slices examined are 19 for control (3 × mock), 13 for 3 × FK, 22 for 3 × FK + anti-TrkB and 14 for 3 × FK + anti-TrkB + anti-p75^NTR^. The scale bars are 10 msec (horizontal) and 1 mV (vertical). (c) The dendritic spine density is shown together with representative images of the dendritic segments. The numbers of segments \[slices\] examined are 41 \[12\] for control, 37 \[11\] for 3 × FK, 47 \[13\] for 3 × FK + anti-TrkB and 45 \[11\] for 3 × FK + anti-TrkB + anti-p75^NTR^. The scale bar indicates 2 μm. The *P* values are 4.09 × 10^−5^ for \*\*\*1, 0.0016 for \*\*2, 3.81 × 10^−11^ for \*\*\*3, 8.34 × 10^−5^ for \*\*\*4, 6.72 × 10^−3^ for \*\*5, 0.039 for \*6, 8.21 × 10^−5^ for \*\*\*7, 2.52 × 10^−11^ for \*\*\*8 and 0.0061 for \*\*9 and 0.0010 for \*\*10.](srep03185-f3){#f3}

![Prolonged application of the anti-p75^NTR^ antibody during repetitive inductions of LTD leads to a reversal of synaptic suppression.\
(a) Timeline of the experimental procedures. (b) The synaptic strength, as indicated by the maximal fEPSP, is shown together with representative recordings. The numbers of slices examined are 16 for control (3 × mock), 17 for 3 × DHPG, 8 for 3 × DHPG + anti-p75^NTR^ and 13 for 3 × DHPG + anti-p75^NTR^ + anti-TrkB. The scale bars are 10 msec (horizontal) and 1 mV (vertical). (c) The dendritic spine density is shown together with representative images of the dendritic segments. The numbers of segments \[slices\] examined are 38 \[8\] for control, 36 \[9\] for 3 × DHPG, 20 \[5\] for 3 × DHPG + anti-p75^NTR^ and 40 \[9\] for 3 × DHPG + anti-p75^NTR^ + anti-TrkB. The scale bar indicates 2 μm. (d, e) The immunoblotting analysis, supporting the alternative activation of TrkB by proBDNF under p75^NTR^-masking conditions. Lysates were prepared 3 hours after the third LTD induction. Five slices were pooled for preparing 1 sample (d). Two bands that are immunopositive to the anti-TrkB antibody are full-length (FL-) and truncated (Trunc-) forms of TrkB[@b47]. The bands are taken out from a single membrane. (For original images of the membrane, see [Supplementary Fig. S4](#s1){ref-type="supplementary-material"} on line). The quantified levels of phosphorylated Trk, total full-length TrkB and p75^NTR^ are shown in (e). The analysis was repeated 8 times (4 times for p75^NTR^), the density of each band was relativized to that of control (3 × mock) for each time, and the mean values are plotted here. The *P* values are 0.016 for \*1, 7.12 × 10^−4^ for \*\*\*2, 1.00 × 10^−7^ for \*\*\*3, 0.019 for \*4, 0.0015 for \*\*5, 0.025 for \*6, 0.0029 for \*\*7, 1.66 × 10^−7^ for \*\*\*8, 0.0087 for \*\*9, 0.0063 for \*\*10 and 0.0032 for \*\*11.](srep03185-f4){#f4}
